HARMONY BIOSCIENCES HOLDINGS, INC. (HRMY) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $1.00K; Additional Paid in Capital, Common StockUSD $731.15M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-727.00K; Retained Earnings (Accumulated Deficit)USD $268.82M.
- 2026-03-31: Common Stock, Value, IssuedUSD $1.00K; Additional Paid in Capital, Common StockUSD $717.37M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-413.00K; Retained Earnings (Accumulated Deficit)USD $193.39M.
- 2025-12-31: Common Stock, Value, IssuedUSD $1.00K; Additional Paid in Capital, Common StockUSD $708.97M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $346.00K; Retained Earnings (Accumulated Deficit)USD $160.90M.
- 2025-09-30: Common Stock, Value, IssuedUSD $1.00K; Additional Paid in Capital, Common StockUSD $696.35M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $357.00K; Retained Earnings (Accumulated Deficit)USD $138.42M.
HARMONY BIOSCIENCES HOLDINGS, INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1.00K | $731.15M | $-727.00K | $268.82M | $999.24M | 3 month · $9.34M 6 month · $19.95M |
| 2026-03-31 | $1.00K | $717.37M | $-413.00K | $193.39M | $910.35M | 3 month · $10.62M |
| 2025-12-31 | $1.00K | $708.97M | $346.00K | $160.90M | $870.22M | 12 month · $44.90M |
| 2025-09-30 | $1.00K | $696.35M | $357.00K | $138.42M | $835.12M | 3 month · $10.97M 9 month · $34.92M |
| 2025-06-30 | $1.00K | $685.29M | $239.00K | $87.55M | $773.08M | 3 month · $11.46M 6 month · $23.95M |
| 2025-03-31 | $1.00K | $672.50M | $245.00K | $47.78M | $720.52M | 3 month · $12.50M |
| 2024-12-31 | $1.00K | $656.87M | $66.00K | $2.22M | $659.15M | 12 month · $42.60M |
| 2024-09-30 | $1.00K | $643.56M | $499.00K | $-47.26M | $596.80M | 3 month · $11.05M 9 month · $32.53M |
| 2024-06-30 | $1.00K | $632.17M | $-234.00K | $-93.35M | $538.58M | 3 month · $11.09M 6 month · $21.48M |
| 2024-03-31 | $1.00K | $620.51M | $-171.00K | $-104.94M | $515.39M | 3 month · $10.39M |
| 2023-12-31 | $1.00K | $610.27M | $2.00K | $-143.28M | $466.99M | 12 month · $31.70M |
| 2023-09-30 | $1.00K | $651.73M | $-516.00K | $-169.88M | $481.33M | 3 month · $7.99M 9 month · $22.84M |
| 2023-06-30 | $1.00K | $694.04M | $-522.00K | $-208.34M | $485.17M | 3 month · $7.65M 6 month · $14.85M |
| 2023-03-31 | $1.00K | $685.72M | $-31.00K | $-242.65M | $443.04M | 3 month · $7.20M |
| 2022-12-31 | $1.00K | $675.12M | $-151.00K | $-272.13M | $402.84M | 12 month · $26.17M |
| 2022-09-30 | $1.00K | $664.70M | $-178.00K | $-320.64M | $343.88M | 3 month · $7.01M 9 month · $18.91M |
| 2022-06-30 | $1.00K | $655.14M | $-29.00K | $-408.58M | $246.53M | 3 month · $7.28M 6 month · $11.91M |
| 2022-03-31 | $1.00K | $646.62M | (m) | $-432.11M | $214.50M | 3 month · $4.63M |
| 2021-12-31 | $1.00K | $640.10M | (m) | $-453.60M | $186.51M | 12 month · $15.66M |
| 2021-09-30 | $1.00K | $628.33M | (m) | $-476.31M | $152.02M | 3 month · $4.25M 9 month · $11.46M |
| 2021-06-30 | $1.00K | $593.24M | (m) | $-466.69M | $126.55M | 3 month · $3.91M 6 month · $7.21M |
| 2021-03-31 | $1.00K | $588.69M | (m) | $-480.81M | $107.88M | 3 month · $3.30M |
| 2020-12-31 | $1.00K | $585.37M | (m) | $-488.19M | $97.18M | 12 month · $4.69M |
| 2020-09-30 | $1.00K | $582.53M | (m) | $-487.99M | $94.55M | 3 month · $1.07M 9 month · $1.87M |
| 2020-06-30 | (m) | (m) | (m) | (m) | $-483.36M | 3 month · $429.00K 6 month · $797.00K |
| 2020-03-31 | (m) | (m) | (m) | (m) | $-472.33M | 3 month · $368.00K |
| 2019-12-31 | (m) | (m) | (m) | $-422.86M | $-422.86M | 12 month · $9.91M |
| 2019-09-30 | (m) | (m) | (m) | (m) | $-384.91M | 3 month · $407.00K 9 month · $1.10M |
| 2019-06-30 | (m) | (m) | (m) | (m) | $-343.63M | (m) |
| 2018-12-31 | (m) | (m) | (m) | (m) | $-242.67M | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |